ONCY
Closed
Oncolytics Biotech Inc
0.75
-0.02 (-2.59%)
Last Update: 01 Jul 2025 23:06:00
Yesterday: 0.773
Day's Range: 0.7412 - 0.81
Send
sign up or login to leave a comment!
When Written:
1.15
Oncolytics Biotech Inc. is a clinical-stage biotechnology company that focuses on the development of oncolytic viruses as potential treatments for various types of cancer. The company's lead product candidate is REOLYSIN, a proprietary formulation of the human reovirus that is designed to selectively target and destroy cancer cells while sparing normal cells.
Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada. The company has ongoing clinical trials in various stages of development for a range of cancers, including breast, lung, ovarian, and pancreatic cancer.
In addition to its clinical programs, Oncolytics Biotech Inc. also collaborates with various academic institutions and pharmaceutical companies to advance the development of oncolytic viruses as a new class of cancer therapeutics. The company is publicly traded on the NASDAQ and the TSX under the ticker symbol ONCY.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada. The company has ongoing clinical trials in various stages of development for a range of cancers, including breast, lung, ovarian, and pancreatic cancer.
In addition to its clinical programs, Oncolytics Biotech Inc. also collaborates with various academic institutions and pharmaceutical companies to advance the development of oncolytic viruses as a new class of cancer therapeutics. The company is publicly traded on the NASDAQ and the TSX under the ticker symbol ONCY.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!
When Written:
1.15
Oncolytics Biotech Inc. is a biotechnology company that focuses on the development and commercialization of oncolytic viruses for the treatment of cancer. The company's lead product, REOLYSIN, is a proprietary formulation of the human reovirus that has been shown to selectively infect and destroy cancer cells while leaving healthy cells unharmed.
Oncolytics Biotech's research and development efforts are focused on identifying new indications for REOLYSIN, as well as developing new oncolytic viruses using its proprietary technology platform. The company has ongoing clinical trials evaluating REOLYSIN in various types of cancer, including breast cancer, lung cancer, and melanoma.
In addition to its clinical development efforts, Oncolytics Biotech has established partnerships with other companies and academic institutions to further advance its research and development programs. The company is headquartered in Calgary, Canada, and has operations in the United States and Europe.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Oncolytics Biotech's research and development efforts are focused on identifying new indications for REOLYSIN, as well as developing new oncolytic viruses using its proprietary technology platform. The company has ongoing clinical trials evaluating REOLYSIN in various types of cancer, including breast cancer, lung cancer, and melanoma.
In addition to its clinical development efforts, Oncolytics Biotech has established partnerships with other companies and academic institutions to further advance its research and development programs. The company is headquartered in Calgary, Canada, and has operations in the United States and Europe.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!